Nucleai

News

Sanofi backs precision oncology firm Nucleai in $33m fundrai...

Israeli startup Nucleai has raised $33 million in a second-round financing that will be used to further its work on using artificial inte

News

AI startup Nucleai has immuno-oncology treatment failures in...

Israeli company Nucleai is putting artificial intelligence to work to discover why so many cancer patients don’t respond to immunotherapies, with the help of Swiss drugmaker De

News

Stéphane Bancel, Moderna's chief executive.

Moderna's Q1 revenues rocket, thanks to ex-US sales

Moderna saw its Q1 sales nearly triple to $389m, almost a threefold rise on the same period of 2025, with international markets driving the increase.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/register.png

Digital

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Editor's Picks